Haigh Adrian
SEC CIK 1717425 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| FENC | FENNEC PHARMACEUTICALS INC. | COO | 0 | — | $414.7K | 6 | 2024-04-15 | 2024-04-19 |
Most active insiders at FENC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Southpoint Capital Advisors LP | 10% | — | $7.50M |
| 2 | Southpoint GP, LLC | 10% | — | $2.04M |
| 3 | Raykov Rosty | Former Dir | — | $1.05M |
| 4 | Andrade Robert | CFO | — | $883.5K |
| 5 | Southpoint Capital Advisors LLC | 10% | — | $806.3K |
| 6 | Brughera Marco Maria | Dir | — | $160.0K |
| 7 | Sayad Pierre Sargis | Chief Medical Off | — | $146.2K |
| 8 | RALLIS CHRIS A | Dir | — | $75.2K |
| 9 | Cioffi Christiana Marie | Chief Strategy Off | — | — |
| 10 | Evans Terry L | Chief Commercial Off | — | — |
Haigh Adrian made no open-market trades at FENC in the last 12 months.
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MA | 2024-04-26 | 2024-04-17+ | FENC | FENNEC PHARMACEUTICALS INC. | Haigh Adrian | COO | M - OptEx | $2.31 | +44.4K | 44.4K | New | +$102.7K |
| MA | 2024-04-26 | 2024-04-15+ | FENC | FENNEC PHARMACEUTICALS INC. | Haigh Adrian | COO | M - OptEx | $2.31 | +44.4K | 44.4K | New | +$102.7K |
| DM | 2024-04-22 | 2024-04-19+ | FENC | FENNEC PHARMACEUTICALS INC. | Haigh Adrian | COO | S - Sale+OE | $9.33 | -44.4K | 0 | -100% | -$414.7K |
| DM | 2024-04-22 | 2024-04-19+ | FENC | FENNEC PHARMACEUTICALS INC. | Haigh Adrian | COO | M - OptEx | $2.31 | +44.4K | 22.2K | New | +$102.7K |
| DM | 2024-04-18 | 2024-04-17+ | FENC | FENNEC PHARMACEUTICALS INC. | Haigh Adrian | COO | S - Sale | $6.04 | 0 | 44.4K | New | $0 |
| DM | 2024-04-16 | 2024-04-15+ | FENC | FENNEC PHARMACEUTICALS INC. | Haigh Adrian | COO | S - Sale | $6.30 | 0 | 0 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations